Keywords: shire, beats, expectations, sales, up, driven, adderall

Shire beats expectations, with sales up 34% driven by Adderall XR and Elaprase

Article | 06 August 2007

Print This

UK drugmaker Shire not only beat consensus forecasts with its second-quarter 2007 results, but also upped its guidance for full-year sales ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in